News

2019/10/30

Medivir presents MIV-818 data at AACR-NCI-EORTC in Boston

Read more
2019/10/10

US National Cancer Institute initiates phase I study of treatment of head and neck cancer patients with Medivir’s birinapant and radiation therapy

Read more
2019/08/28

MEDIVIR AB – INTERIM REPORT JANUARY – JUNE 2019

Read more

Partner with Medivir

Partnering is an important element of our business strategy. Together with our partners we have been successful in taking two products from research, through clinical development to launch on a global scale.